Rankings
▼
Calendar
MIRM Q2 2019 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$14M
Net Income
-$14M
EPS (Diluted)
$-0.59
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$104M
Total Liabilities
$132M
Stockholders' Equity
-$28M
Cash & Equivalents
$42M
← FY 2019
All Quarters
Q3 2019 →
